Resonance Health
Resonance Health is a MedTech company specializing in non-invasive medical imaging analysis, particularly in iron overload and liver disease management. Their portfolio includes post-MRI analysis tools like FerriScan and HepaFatScan, providing quantitative calculations and evaluations essential for disease management and clinical trials.
Short position
Resonance Health (ASX:RHT) has 0.02% of its shares on issue reported as short positions as of 25 Sept 2026, or about 71,783 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.23% in February 2019. RHT is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4RHT community
Research Threads
Bull, bear, catalyst, and news-reaction posts tied directly to RHT.
Start the first RHT research thread
Anchor the conversation with a thesis, a catalyst, or a question worth debating.